diquafosol tetrasodium (INS365) ophthalmic solution

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Dry Eye Disease

Phase 2

A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease

CompletedNCT00679718

Merck Sharp & Dohme LLCDry Eye Disease

Start: 2000-01-31End: 2000-07-31Target: 150Updated: 2015-08-27

A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution

CompletedNCT00680108

Merck Sharp & Dohme LLCDry Eye Disease

Start: 1999-09-30End: 2000-05-31Target: 62Updated: 2015-08-27

Phase 3

Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease

CompletedNCT00404131

Merck Sharp & Dohme LLCDry Eye Disease

Start: 2001-03-31End: 2001-12-31Target: 500Updated: 2016-11-29

Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease

CompletedNCT00403715

Merck Sharp & Dohme LLCDry Eye Disease

Start: 2001-02-28End: 2002-09-30Target: 500Updated: 2016-11-29